The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against WuXi PharmaTech (Cayman) Inc. (“WuXi” or “the Company”) (NYSE: WX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between September 1, 2015 and December 10, 2015, inclusive (the ''Class Period''), are encouraged to contact the firm before April 23, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. WuXi failed to provide material information and made misrepresentations in public statements to investors, making it impossible for them to make an informed decision about the proposed merger between the Company and New WuXi Life Science Limited and WuXi Merger Limited for approximately $3.62 billion. The Company planned to spin-off the subsidiaries as publicly-traded entities for their own gain. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about WuXi, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law FirmBrian Schall, Esq.,Sherin Mahdavian, Esq.,www.schallfirm.comOffice: 310-301-3335Cell: 424-303-1964info@schallfirm.com

(NYSE:WX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas .
(NYSE:WX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas .